| Fri, Jul 3, 2009 | | • | [$$] Research Reports
at Barron's Online (Fri, Jul 3)
| | Thu, Jun 18, 2009 | | • | Seattle Genetics Initiates Phase II Trial of SGN-35 for Anaplastic Large Cell Lymphoma
Business Wire (Thu, Jun 18)
| | Mon, Jun 8, 2009 | | • | Seattle Genetics Reports Data from SGN-35 Every Three Week Dosing Phase I Trial in Lymphoma
Business Wire (Mon, Jun 8)
| | • | Seattle Genetics Presents Final Lintuzumab Phase I Clinical Data
Business Wire (Mon, Jun 8)
| | Thu, Jun 4, 2009 | | • | Seattle Genetics to Present at the Needham Life Sciences Conference
Business Wire (Thu, Jun 4)
| | Mon, Jun 1, 2009 | | • | Seattle Genetics Reports Data from a Weekly Dosing Phase I Clinical Trial of SGN-35 in Lymphoma
Business Wire (Mon, Jun 1)
| | Thu, May 28, 2009 | | • | Small-Cap Biotechs Pop Before Conference
at TheStreet.com (Thu, May 28)
| | Wed, May 27, 2009 | | • | Top Biotech Picks for ASCO 2009 (Part II)
at Seeking Alpha (Wed, May 27)
| | Thu, May 21, 2009 | | • | SEATTLE GENETICS INC /WA Files SEC form 8-K, Unregistered Sale of Equity Securities
EDGAR Online (Thu, May 21)
| | • | Seattle Genetics to Present SGN-35 and Lintuzumab Clinical Data at the European Hematology Association Congress
Business Wire (Thu, May 21)
| | Fri, May 15, 2009 | | • | SEATTLE GENETICS INC /WA Financials
EDGAR Online Financials (Fri, May 15)
| | Thu, May 14, 2009 | | • | Seattle Genetics Announces SGN-35 Clinical Data to be Presented at the American Society of Clinical Oncology Annual Meeting
Business Wire (Thu, May 14)
| | Fri, May 8, 2009 | | • | SEATTLE GENETICS INC /WA Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, May 8)
| | • | Seattle Genetics to Present at Upcoming Investor Conferences
Business Wire (Fri, May 8)
| | Sat, Apr 25, 2009 | | • | New Star Analyst Rankings for Seattle Genetics, Inc.
StarMine (Sat, Apr 25)
| | Thu, Apr 23, 2009 | | • | Seattle Genetics Earnings Call scheduled for 5:00 pm ET today
CCBN (Thu, Apr 23)
| | • | SEATTLE GENETICS INC /WA Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
EDGAR Online (Thu, Apr 23)
| | • | Seattle Genetics Reports Product Development Progress and First Quarter 2009 Financial Results
Business Wire (Thu, Apr 23)
| | • | Q1 2009 Seattle Genetics Earnings Release - After Market Close
CCBN (Thu, Apr 23)
| | Wed, Apr 22, 2009 | | • | Illuminating Stock Option Problems
at Motley Fool (Wed, Apr 22)
|
Add SGEN News to My Yahoo!:
 
| |
|
0.45% Nasdaq 
0.20%
Headlines
